Stockscreener 앱 받기
6.20
6.35%
0.37
시간 외 거래:
6.03
-0.17
-2.74%
전일 마감가:
$5.83
열려 있는:
$5.96
하루 거래량:
18,768
Relative Volume:
1.64
시가총액:
$86.10M
수익:
$57.94M
순이익/손실:
$-2.34M
주가수익비율:
-37.21
EPS:
-0.1666
순현금흐름:
$3.82M
1주 성능:
+8.01%
1개월 성능:
+2.48%
6개월 성능:
-5.56%
1년 성능:
-38.92%
1일 변동 폭
$5.8413
$6.20
1주일 범위
$5.50
$6.34
52주 변동 폭
$5.50
$10.25
Champions Oncology Inc Stock (CSBR) Company Profile
명칭
Champions Oncology Inc
전화
410-369-0365
주소
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.20 | 80.96M | 57.94M | -2.34M | 3.82M | -0.1666 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-12 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-11-18 | 개시 | The Benchmark Company | Speculative Buy |
Champions Oncology Inc 주식(CSBR)의 최신 뉴스
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ... By GuruFocus - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 earnings call transcript - MSN
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN
Champions Oncology reports Q3 revenue of $16.6 million - Investing.com Nigeria
A activityTrade Risk Assessment & Verified Momentum Stock Watchlist - mfd.ru
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 Earnings Call Transcript - Insider Monkey
Discipline and Rules-Based Execution in CSBR Response - Stock Traders Daily
Champions Oncology reports Q3 revenue of $16.6 million By Investing.com - Investing.com Australia
Champions Oncology (CSBR) Earnings Transcript - AOL.com
Champions Oncology (CSBR) Earnings Transcript - The Motley Fool
Champions Oncology, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Champions Oncology, Inc. Q3 2026 Financial Report: Balance Sheet, Income Statement, and Key Financial Highlights - Minichart
Earnings call transcript: Champions Oncology Q3 2026 misses EPS forecast, revenue grows - Investing.com
CSBR: Record core study revenue and positive adjusted EBITDA despite lower total revenue year-over-year - TradingView
Barco Announces HDR by Barco is confirmed as a format for THE DEVIL WEARS PRADA 2, THE MANDALORIAN AND GROGU, and TOY STORY 5 – NEWSnet Michigan - michigan.newsnetmedia.com
Champions Oncology earnings missed by $0.04, revenue topped estimates - Investing.com Canada
American Properties Realty, Inc. Leadership Attends NAHB International Builders’ Show in Florida - michigan.newsnetmedia.com
John Lauer, EVP and CCO, Announces Retirement Plans - michigan.newsnetmedia.com
Rising costs push Champions Oncology (NASDAQ: CSBR) from profit to loss - Stock Titan
CHAMPIONS ONCOLOGY ($CSBR) Releases Q3 2026 Earnings - Quiver Quantitative
Champions Oncology Q3 revenue dips 3% - TradingView
CSBR: Record study service revenue and positive adjusted EBITDA achieved, with margin improvement expected - TradingView
Champions Oncology (NASDAQ: CSBR) Q3 revenue flat as margins fall - Stock Titan
Champions Oncology Reports Revenue of $16.6 Million - marketscreener.com
Cancer research group hits record $16.6M sales but swings to Q3 loss - Stock Titan
Fund Flows: Is Champions Oncology Inc benefiting from innovation trendsBear Alert & Verified Chart Pattern Signals - baoquankhu1.vn
Tom Brady Retirement Struggle Explains Midlife Male Identity Crisis: New Guide - michigan.newsnetmedia.com
Earnings Scheduled For March 12, 2026 - Benzinga
Epson Robots to Showcase Scalable Retail Automation at Shoptalk Spring 2026 - michigan.newsnetmedia.com
Sir Nick Clegg appointed to Efekta Education Group Advisory Board - michigan.newsnetmedia.com
Momentum Shift: How does Champions Oncology Inc. score in quality rankingsEarnings Recap Report & Low Volatility Stock Recommendations - baoquankhu1.vn
International Women’s Day Highlights 2026: Honoring Women in Oncology - Oncodaily
LCUT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Can SUPV stock sustain double digit ROEAnalyst Upgrade & AI Powered Market Entry Strategies - Naître et grandir
Aug Decliners: Is Champions Oncology Inc showing insider buyingEarnings Beat & Real-Time Buy Signal Alerts - baoquankhu1.vn
Can Atea Pharmaceuticals Inc stock double in the next year2025 Winners & Losers & Consistent Income Trade Ideas - baoquankhu1.vn
Champions Oncology Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 - Weatherford Democrat
Cancer research firm Champions Oncology plans March 12 Q3 financial call - Stock Titan
CSBR SEC FilingsChampions Oncolo 10-K, 10-Q, 8-K Forms - Stock Titan
Behavioral Patterns of CSBR and Institutional Flows - Stock Traders Daily
IMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FGBI PE Ratio & Valuation, Is FGBI Overvalued - Intellectia AI
SFBC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NOTV Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is the earnings history of CREVCEO Change & Low Drawdown Trading Techniques - mfd.ru
Whale Trades: Will Champions Oncology Inc outperform the market in YEARLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
OKYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn
Patient Derived Xenografts/PDX Models Market Research and Global Forecast Report 2025-2030 - GlobeNewswire
Champions Oncology (CSBR) Stock Analysis Report | Financials & Insights - Benzinga Japan
Champions Oncology Inc (CSBR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):